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Background. Subjective sleep disturbances increase duringmenopause. Some problems commonly encountered duringmenopause,
such as hot flushes and sweating at night, can cause women to have difficulty in sleeping.These complaints can influence quality of
life of menopausal women.Methods. This cross-sectional study was performed on menopausal women attending health centers in
Qazvin for periodic assessments. We measured excessive daytime sleepiness by Epworth sleepiness scale (ESS), obstructive sleep
apnea (OSA) by the Berlin questionnaire, and insomnia by the insomnia severity index (ISI). We evaluate quality of life by the
Menopause specific quality of life questionnaire (MENQOL).Results. A total of 380menopausal women entered the study.Mean age
of participated women was 57.6 ± 6.02. Mean duration of menopause was 6.3 ± 4.6.The frequency of severe andmoderate insomnia
was 8.4% (32) and 11.8% (45). Severe daytime sleepiness (ESS≥ 10) was present in 27.9% (80) of the participants. Multivariate
analytic results show that insomnia and daytime sleepiness have independent negative impact on each domain and total score
of MENQOL questionnaire. Conclusion. According to our findings, EDS and insomnia are frequent in menopausal women. Both
EDS and insomnia have significant quality of life impairment.
1. Introduction
Across the lifespan, sleep disturbances are more prevalent in
women than men.
Pregnancy, menstrual-related fluctuations, and the men-
opause may cause high prevalence of sleep disturbances in
women [1–3]. Sleep disorders are more common during the
menopausal transition as compared to premenopausal years
[4]. During the menopause, progressive decline in estrogen
and progesterone levels are frequently related to vasomotor
symptoms, night sweats, fatigue, mood alterations, irritabil-
ity, headache, palpitation, and sleep disorders [5, 6]. These
symptoms may be subtle to severe and disabling. Sleeping
disturbances are among the most frequent health complaints
of women during menopause.They include disorders such as
difficulty of falling asleep, fractioned sleep, night-time awak-
ening, inability of resuming sleep, problems in waking up,
fatigue, and daytime sleepiness [7, 8].
Insomnia is a common disorder in menopausal women
with the prevalence of 28–63% based on different studies [9].
Many women, during the menopause, achieve less than 6 h
of sleep on a regular basis, becoming at higher risk for short-
term and long-term problems. The main effects of short-
term sleep deprivation include anxiety, drowsiness, memory
and cognitive impairment, and stressed relationship.Also, the
most important long-term effects of sleep deprivation include
high blood pressure, heart attack, stroke, and depression, and
other mood disorders. Overall, insomnia is a more common
disorder among thewomen than themen, and thosewith pre-
existing chronic insomnia may have increased vulnerability
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for an exacerbation of sleep disturbance during menopause
[10, 11].
Studies have shown that the prevalence and severity of
sleep apnea increases duringmenopause.Menopausalwomen
are prone to higher prevalence of obstructive sleep apnea due
to weight gain and decrease in estrogen and progesterone
levels [12, 13].
A study on 589 middle aged women showed that mild
obstructive sleep apnea was 2.6 times and severe obstructive
sleep apnea was 3.5 times more prevalent in postmenopausal
than in premenopausal women [14].
Fatigue and daytime sleepiness are other symptoms of
sleep disorders in premenopausal women [15]. In one study,
149 women aged 40–59 years were evaluated regarding
daytime sleepiness. They showed the prevalence of daytime
sleepiness to be 33.6%. Postmenopausal status, sedentarism,
and hot flush were risk factors for increased daytime sleepi-
ness [16]. Insomnia and obstructive sleep apnea can also
increase daytime sleepiness. Several studies on different
populations have shown that sleep quality is an important
variable in overall health and quality of life [1, 4, 17]. Inves-
tigations on the patients with epilepsy, end stage cancer, and
obstructive pulmonary disease have shown that sleep disor-
ders can decrease the quality of life [18–20]. In one study in
2009, the correlation between different sleep disorders and
quality of life was investigated in 887 women aged 45–59
years. They showed a prevalence of 54% for sleep disorders
andwomenwith different sleep disorders had lower quality of
life regarding vasomotor, psychosocial, physical, and sexual
aspects [21].
In different studies in Iran, high prevalence of sleep dis-
orders in menopausal women has been shown. One study
showed a prevalence of 70% for sleep disorders in women
aged 50–60 years [22, 23]. However, there is no study regard-
ing the effect of sleep disorders on quality of life in meno-
pausal women in Iran.
This study was performed to evaluate the prevalence of
insomnia, daytime sleepiness, and obstructive sleep apnea in
menopausal women. We also evaluated the effect of these
disorders on quality of life.
2. Methods and Materials
This cross-sectional study was performed on menopausal
women attending health centers in Qazvin for periodic
assessments. In a three-month period, all women aged 50–60
years with a history of at least one year of amenorrhea entered
the study. Patients with a history of hysterectomy, premature
menopause, hormonal replacement therapy, diabetes melli-
tus, hypertension, hypnotic drug consumption, and heart
failure were excluded from the study. All women filled out
a questionnaire containing demographic data, age, years of
menopause, family income, and marital state. Height and
weight of all cases were measured.
Insomnia severity index (ISI), Epworth sleepiness scale
(ESS), and Berlin questionnaire (BQ) were used to assess
sleep disorders. Menopause specific quality of life question-
naire (MENQOL) was used to evaluate the quality of life.
The Persian translation of all questionnaires used in the
study was confirmed to be valid in previous studies. The
Cronbach’s Alpha values in the previous studies conducted in
the Persian language were 0.81, 0.89, 0.79, and 0.77, respec-
tively [24–27].
The insomnia severity index is composed of seven items
measuring the symptoms and consequences of insomnia.The
perceived severity of each item is rated on a 0–4 Likert scale
ranging from 0 (not at all) to 4 (very severe). A total score “8”
or greater indicates insomnia [24].
The Epworth Sleepiness Scale consist eight questions that
subjectively evaluate urge of patients to sleep of different
situations in life. ESS was designed based on Likert scale
rating from 0 to 3. Scores ≥10 are considered excessive day-
time sleepiness [25].
The BQ includes eight items about snoring, daytime
somnolence, and history of hypertension. The patients were
categorized as being at a low risk or high risk of having sleep
apnea [26].
The MENQOL is a 29-item questionnaire that assesses
the effects of the menopausal symptoms, divided into 4 cate-
gories, physical (16 items), vasomotor (3 items), psychological
(7 items), and sexual (3 items) on quality of life in post-
menopausal women. The likert scale with seven points scor-
ing system used during the administration of questionnaire.
For all items, this seven-point likert scale is converted to
an eight-point scale, ranging from 1 (no experience of meno-
pausal symptom) to 8 (themost severe symptom).The higher
the scores are considered to be the worse the quality of life
[27].
In our samples, Cronbach’s alpha values for these ques-
tionnaires were found to be 0.82, 0.78, 0.88, and 0.83, respec-
tively.
The questionnaires were completed by a trained person
and the participants were requested to answer the questions
carefully.
All participants were informed about the research and
written consent obtained.
Data analysis was performed using SPSS software version
13. Mean and SD scores were calculated for numerical vari-
ables and number and percent for categorical variables. We
performed multiple regression analysis between dependent
variable (insomnia, EDS, and OSA) and independent vari-
ables (age, duration of menopause, income, marital status,
and BMI). We also performed multiple regression analysis
between subscales of quality of life and insomnia, EDS and
OSA as independent variables. 𝑃 value <0.05 was considered
statistically significant.
3. Results
A total of 380 menopausal women entered the study. Demo-
graphic data is shown in Table 1. The mean age of the partici-
pants was 57.6 (6.02) years with the maximum andminimum
of 77 and 46, respectively. The mean duration of menopause
was 6.3 (4.6) years with the maximum and minimum of 25
and 1, respectively. The mean duration of night sleep was 7.6
(5.2) hours. The results of the answers to each part of the
MENQOL questionnaire was 3.9 (1.9), 17.4 (7.1), 32.5 (11.9),
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Table 1: Demographic and clinical characteristics of participants.
Variable 𝑛 (%) or mean (SD)
Age (years) 57.6 (6.02)
Body mass index (kg/m2) 26.6 (4.7)
Duration of menopause (years) 6.3 (4.6)
Income (Rials) 668 (45.7) (×104)
Marital status
Single 58 (15.3%)
Married 322 (84.7%)
ISI∗ 12.7 (5.1)
ESS∗∗ 8.9 (3.7)
OSA∗∗∗
Low risk 259 (68.2%)
High risk 121 (31.8%)
Vasomotor domain 3.9 (1.9)
Psychosocial domain 17.4 (7.1)
Physical domain 32.5 (11.9)
Sexual domain 3.1 (1.3)
Total score of MENQOL∗∗∗∗ 54.5 (19.6)
Data are presented by numbers (percentage) or mean (SD).
∗ISI: insomnia severity index.
∗∗ESS: Epworth sleepiness scale.
∗∗∗OSA: obstructive sleep apnea.
∗∗∗∗MENQOL: menopause specific quality of life.
and 3.1 (1.3) in the subscales of vasomotor, psychosocial, phys-
ical, and sexual aspects, respectively. The frequency of severe
and moderate insomnia was 8.4% (32) and 11.8% (45). Day-
time sleepiness (ESS ≥ 10) was present in 27.9% (80) of the
participants.
As shown in Table 2, insomnia has a strong statistical cor-
relationwith age andduration ofmenopause.With increasing
age and duration of menopause, the frequency of insomnia
increases. In regard to daytime sleepiness, there was only
relation between daytime sleepiness and BMI. It is also shown
that the frequency of OSA increases with increasing BMI.
Table 3 shows that menopausal women with daytime
sleepiness or insomnia have lower scores in all domains of
menopausal-specific quality of life questionnaire and also in
total score. On the other hand, women with the diagnosis of
obstructive sleep apnea based on Berlin questionnaire had
lower scores in the psychosocial domain of the questionnaire.
Multivariate analytic results (Table 4) show that insomnia
and daytime sleepiness have independent negative impact
on each domain and total score of MENQOL questionnaire.
However, obstructive sleep apnea has negative impact only on
psychosocial domain of the questionnaire.
4. Discussion
The results of the present study showed that the frequency
of insomnia and daytime sleepiness in participating women
were higher than in the general population. It was also shown
that both insomnia and daytime sleepiness had indepen-
dently negative impact on all aspects of quality of life butOSA
had negative impact only on psychosocial domain of ques-
tionnaire.
In regard to high prevalence of sleep disorders in men-
opausal women, different studies have been performed to
determine the causative factors. In one cross-sectional study,
the prevalence of daytime sleepiness and its risk factors was
evaluated in 149 women aged 40–59 years. The authors used
Epworth questionnaire to assess daytime sleepiness. They
reported that 33.6% of the participants had daytime sleepi-
ness. They showed that sedentarism and hot flush were the
most important risk factors for increased daytime sleepiness
[16]. We showed a correlation between increased BMI and
sleepiness. This correlates with the findings of other studies
because sedentarism leads to increased BMI [16, 23].
In present study, the prevalence of moderate to severe
insomnia was 20% that was higher in contrast to a similar
study [10]. Increasing age and duration of menopause were
the most important risk factors of insomnia and this corre-
lates well with the results of the bulk of studies.
In one study regarding the risk factors of insomnia in
menopausal women, the authors showed that the severity of
hot flash and sedentarism had a role in insomnia but there
was no link between age and insomnia [10]. The different
results can be explained by the difference between the age
ranges of the study population. The median age in our study
was 58 but it was 48 in their series. However, the mean sleep
time in our series was shown to be equal to the proposed time
for sleep.
Studies using polysomnography showed that menopausal
women did not have lower sleep time than the others. They
had lower sleep quality. Also, in other studies, the women had
a trend to have a higher amount of sleep time [1, 28].
Sleep disturbances duringmenopause are often attributed
to nocturnal hot flashes and sweats associated with changing
hormone patterns. Hot flashes and night sweating can disrupt
sleep. Estrogen leads to shorter sleep latency and increased
number and duration of REM phase of sleep. Decreased
estrogen level causes longer sleep latency and shorter REM
sleep leading to tiredness after awaking [12, 29].
The results of the present study showed that menopausal
womenhad lower quality of life and the hot flashwas themost
common complain. The results of other studies showed that
vasomotor symptoms during menopause can lead to stress
and sleep disorders [21].
In this study we showed the negative impact of sleep dis-
orders especially insomnia and daytime sleepiness on quality
of life. Other studies on different populations using different
questionnaires also showed similar results [1, 10, 16].
One study evaluated 2800 males and females in the age
range of 53–97 years.The authors showed that sleep disorders
especially insomnia are related to lower quality of life.
They used SF-36 questionnaire for quality of life assessment
[30]. Another study comparing patients with insomnia with
healthy controls showed that insomnia patients hadmarkedly
lower scores in all domains of quality of life.
As referred to study results, we can conclude that insom-
nia anddaytime sleepiness can lead to somatic pains, impaired
social relationships, and psychosocial and sexual problems.
We also found a relation between OSA and psychosocial
domain. Several studies have shown the negative impact of
OSA on memory and concentration.
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Table 2: Multiple regression analysis between demographic and clinical characteristics and EDS, insomnia, and OSA.
Insomnia Excessive daytime sleepiness Obstructive sleep apnea
Beta 𝑃 value 𝑅2 Beta 𝑃 value 𝑅2 Beta 𝑃 value 𝑅2
Age 0.62 0.03
0.35
0.004 0.09
0.46
0.04 0.7
0.54
Body mass index 0.53 0.6 0.32 0.01 0.59 0.005
Duration of menopause 0.71 0.007 0.005 0.4 0.06 0.8
Income 0.42 0.8 0.88 0.07 0.82 0.09
Marital status 0.1 0.4 0.52 0.3 0.19 0.1
Table 3: Total score and mean (SD) MENQOL∗ subscale score in relation to insomnia, EDS∗∗, and OSA∗∗∗.
With insomnia Without insomnia
𝑃 value With EDS Without EDS 𝑃 value With OSA Without OSA 𝑃 value
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Total score 62.9 (31.7) 43.5 (21.3) 0.005 74.2 (34.9) 47 (22.7) <0.001 59.1 (30.1) 53.6 (29.2) 0.21
Vasomotor domain 3.6 (4.01) 1.9 (2.2) 0.002 4.6 (4.3) 2.3 (2.7) 0.006 3.3 (2.8) 2.8 (3.4) 0.25
Psychosocial domain 19.1 (9.03) 14.1 (8.8) <0.001 19.8 (8.9) 16.02 (9.2) <0.001 19.7 (8.9) 14.3 (9.2) 0.006
Physical domain 37.02 (20.2) 25.2 (13.2) 0.001 44.2 (21.1) 27.4 (15.2) <0.001 31.7 (20.5) 32.1 (17.9) 0.87
Sexual domain 3.2 (4.1) 2.9 (3.1) 0.009 5.6 (4.9) 2.03 (2.5) 0.01 3.7 (4.3) 2.9 (3.6) 0.14
∗MENQOL: menopause specific quality of life.
∗∗EDS: excessive daytime sleepiness.
∗∗∗OSA: obstructive sleep apnea.
Table 4: Multiple regression analysis between demographic, clinical characteristics, sleep disturbances, and MENQOL∗ subscales.
Total score Vasomotor domain Psychosocial domain Physical domain Sexual domain
Beta 𝑃 𝑅2 Beta 𝑃 𝑅2 Beta 𝑃 𝑅2 Beta 𝑃 𝑅2 Beta 𝑃 𝑅2
Age 0.609 0.24
0.39
0.44 0.37
0.52
−0.11 0.74
0.37
0.68 0.45
0.49
0.17 0.15
0.53
Body mass index 0.047 0.43 0.62 0.5 −0.71 0.82 0.64 0.6 0.76 0.13
Duration of menopause 0.27 0.07 0.073 0.51 −0.408 0.081 0.52 0.2 0.055 0.61
Income 0.205 0.11 −0.32 0.62 0.33 0.82 0.702 0.75 0.13 0.1
Marital status −0.16 0.68 0.18 0.41 0.081 0.31 0.43 0.45 −0.61 0.09
Insomnia −0.13 0.01 −0.405 0.004 −0.11 0.03 −0.35 <0.001 −0.27 0.008
EDS∗∗ −0.45 0.03 −0.51 0.02 −0.902 0.003 −0.72 0.007 −0.338 0.04
OSA∗∗∗ 0.604 0.37 0.17 0.91 −0.407 0.016 0.18 0.28 0.223 0.18
∗MENQOL: menopause specific quality of life.
∗∗EDS: excessive daytime sleepiness.
∗∗∗OSA: obstructive sleep apnea.
Finally, as for the limitations of the present study one can
mention its cross-sectional design.As in this study, the factors
of age and duration of menopause had effect on insomnia; we
suggest a cohort study to be designed for long term evaluation
ofwomen.Theother limitation of the studywas the subjective
evaluation of sleep disorders. Using objective methods like
polysomnography and actigraphy can lead to more strict
results in future studies. The point of power in this study was
its relatively big study population which could reflect the real
condition in the society.
5. Conclusion
As regards the results of this study, a normal sleep is an impor-
tant factor for general health. Quality of life includes psycho-
somatic, social, and physical aspects and sleep disorders can
impair all of them. We can conclude that in periodic assess-
ments of menopausal women, it is necessary to concentrate
on diagnosis and treatment of sleep disorders. In addition
evaluation of effectiveness of different treatment methods is
necessary in this group. It is also recommended to educate
this group regarding sleep health. It is necessary to mention
that the results of this study are primary and need to be con-
firmed by larger studies.
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